Prof. Dr. CİHAN URAS

Yayın Ağı

Makaleler 106

1. Locoregional Treatment in De Novo Bone-Only Metastatic Breast Cancer: Prospective, Multi-Institutional Real-World Data, BOMETIN, Protocol MF14-1a

Soran A., Göktepe B., Demirors B., Aytac O., Ozbas S., Dogan L., et al.

Current Oncology , cilt.32, sa.10, 2025 (SCI-Expanded, Scopus)

2. Survival of the Patients With Breast Cancer Who Underwent Oncotype DX Recurrence Score Testing: Long-Term Survival Update of a Prospective Multicenter Study in Türkiye According to Different Cut-Offs

Özkurt E., Ordu Ç., Koç E., Gokmen E., Ozdogan M., Guler N., et al.

World Journal of Surgery , cilt.49, sa.9, ss.2303-2313, 2025 (SCI-Expanded, Scopus)

3. Axillary dissection for low-volume nodal involvement after neoadjuvant therapy in breast cancer: multicentre AXSANA cohort study

Kühn T., Banys-Paluchowski M., Ditsch N., Stickeler E., Hauptmann M., Schroth J., et al.

BJS-BRITISH JOURNAL OF SURGERY , cilt.112, sa.9, 2025 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

4. Comparison of Early Results of Laparoscopic Transabdominal Preperitoneal and Total Extraperitoneal Repair in Recurrent Inguinal Hernia

Atar C., Capkinoglu E., Yavuz B., Demirel A. O., Uras C.

JOURNAL OF LAPAROENDOSCOPIC & ADVANCED SURGICAL TECHNIQUES , cilt.35, ss.659-663, 2025 (SCI-Expanded, Scopus)

5. Causes of diagnostic and treatment delays in locally advanced breast cancer: a nationwide multicenter survey and electronic health records analysis in Turkiye

Karadeniz Cakmak G., Tali U., Balbaloglu H., Tasdoven I., Ozkurt E., KARANLIK H., et al.

EUROPEAN JOURNAL OF PUBLIC HEALTH , 2025 (SCI-Expanded, SSCI, Scopus) Sürdürülebilir Kalkınma

6. Omitting Axillary Dissection in Triple-Negative and HER2-Overexpressed Breast Cancers With Positive Sentinel Lymph Nodes During Upfront Surgery: SENATURK-OTHELLO Study

Cabıoğlu N., Karanlık H., Özmen V., Tükenmez M., İğci A., Aytin Y. E., et al.

Clinical Breast Cancer , cilt.25, sa.5, ss.455-463, 2025 (SCI-Expanded, Scopus)

7. Association of Mitochondrial DNA Copy Number Variations with Triple-Negative Breast Cancer: A Potential Biomarker Study

Manto K., Ustun Yilmaz S., PALA KARA Z., KARA H., TOKAT F., AKYERLİ BOYLU C., et al.

DISEASES , cilt.13, sa.6, 2025 (ESCI, Scopus) Sürdürülebilir Kalkınma

8. Comparison of Clinicopathologic Features and Survival Outcomes of Pleomorphic Lobular, Classical Lobular, and Invasive Ductal Carcinoma

Sanli A. N., Kara H., Tekcan Sanli D. E., Arıkan A. E., Cabioglu N., Uras C.

World Journal of Surgery , cilt.49, sa.6, ss.1406-1417, 2025 (SCI-Expanded, Scopus)

9. Omission of axillary dissection after neoadjuvant systemic treatment in initially node-positive HER2-overexpressed and triple-negative breast cancer patients: SENATURK OTHER-NAC study

Cabıoğlu N., KARANLIK H., İğci A., URAS C., DÜLGEROĞLU O., Karadeniz Çakmak G., et al.

European Journal of Surgical Oncology , cilt.51, sa.6, 2025 (SCI-Expanded, Scopus)

10. Omitting axillary dissection in Triple-negative and HER2-overexpressed breast cancers with positive sentinel Lymph nOdes during upfront surgery: OTHELLO Study

Cabioglu N., KARANLIK H., Ozmen V., TÜKENMEZ M., Igci A., Aytin Y. E., et al.

CLINICAL CANCER RESEARCH , cilt.31, sa.12, 2025 (SCI-Expanded, Scopus)

11. Relationships Between Breast Edema and Axillary Lymph Node Metastasis in Breast Cancer

Deniz Altıntaş D., ICTEN S. G., Taşkın F., URAS C.

Diagnostics , cilt.15, sa.11, 2025 (SCI-Expanded, Scopus)

12. The Etiologic Causes of Diagnostic Delay in Locally Advanced Breast Cancer: _x000B_A Multicentric Nationwide Trial

Cakmak G. K., Ozkurt E., KARANLIK H., Dogan L., Gunay S., Basim P., et al.

CLINICAL CANCER RESEARCH , cilt.31, sa.12, 2025 (SCI-Expanded, Scopus)

13. Omitting axillary dissection in Triple-negative and HER2-overexpressed cancers After neoadjuvant Chemotherapy: OTHER-NAC Study

Cabioglu N., KARANLIK H., Sezer A., Igci A., Dulgeroglu O., Cakmak G. K., et al.

CLINICAL CANCER RESEARCH , cilt.31, sa.12, 2025 (SCI-Expanded, Scopus)

14. ASO Visual Abstract: Breast Cancer Recurrence in Initially Clinically Node-Positive Patients Undergoing Sentinel Lymph Node Biopsy after Neoadjuvant Chemotherapy in the NEOSENTITURK-trials MF18-02/18-03

Cabioglu N., Karanlik H., Igci A., Muslumanoglu M., Gulcelik M. A., Uras C., et al.

Annals of surgical oncology , cilt.32, sa.5, ss.3345-3347, 2025 (SCI-Expanded, Scopus)

15. De-Escalation of Nodal Surgery in Clinically Node-Positive Breast Cancer

Cabioǧlu N., Koçer H. B., Karanlik H., Gülçelik M. A., Iǧci A., Müslümanoǧlu M., et al.

JAMA Surgery , cilt.160, sa.3, ss.257-266, 2025 (SCI-Expanded, Scopus)

16. Nodal Burden and Oncologic Outcomes in Patients With Residual Isolated Tumor Cells After Neoadjuvant Chemotherapy (ypN0i+): The OPBC-05/ICARO Study

Montagna G., Laws A., Ferrucci M., Mrdutt M. M., Sun S. X., BADEMLER S., et al.

JOURNAL OF CLINICAL ONCOLOGY , cilt.43, sa.7, 2025 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

17. ASO Author Reflections: Nodal Recurrence Is Rare in Patients with cN+/ycN0 Breast Cancer after Neoadjuvant Chemotherapy Regardless of the Extent of Axillary Surgery or Nodal Pathology in the NEOSENTITURK-Trials MF18-02/18-03 Provided Regional Nodal Irradiation Is Administered

Cabioglu N., KARANLIK H., Igci A., Muslumanoglu M., Gulcelik M. A., URAS C., et al.

Annals of Surgical Oncology , cilt.32, sa.2, ss.971-972, 2025 (SCI-Expanded, Scopus)

18. Breast Cancer Recurrence in Initially Clinically Node-Positive Patients Undergoing Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in the NEOSENTITURK-Trials MF18-02/18-03

Cabioglu N., Karanlik H., Igci A., Muslumanoglu M., Gulcelik M. A., Uras C., et al.

Annals of Surgical Oncology , cilt.32, sa.2, ss.952-966, 2025 (SCI-Expanded, Scopus)

19. Examining the Correlation and Concordance Between Ki-67 Expression and Oncotype DX Recurrence Score: Findings from a Multicenter Study in Turkey

URAS C., Tsoulos N., Giannoulakis S., Kapetsis G., Ergoren M. C., Olgun P., et al.

BREAST , cilt.80, 2025 (SCI-Expanded, Scopus)

20. Combined analysis of the MF18-02/MF18-03 NEOSENTITURK studies: ypN-positive disease does not necessitate axillary lymph node dissection in patients with breast cancer with a good response to neoadjuvant chemotherapy as long as radiotherapy is provided

Muslumanoglu M., Cabioglu N., Igci A., Karanlık H., Kocer H. B., Senol K., et al.

Cancer , cilt.131, sa.1, 2025 (SCI-Expanded, Scopus)

21. Utilization of Serratus Muscle-Fascia Flap to Ensure Implant Stability in Prepectoral Direct-to-Implant Reconstruction

Sağır M., Güven E., Saylik O., ÇAPKINOĞLU E., URAS C.

Aesthetic Plastic Surgery , 2025 (SCI-Expanded, Scopus)

22. A New Convenient Incision Model of the Nipple-Sparing Mastectomy: Lateralized Parabolic Multiplanar Incision

Sagir M., Guven E., Saylik O., DÜLGEROĞLU O., URAS C.

AESTHETIC PLASTIC SURGERY , cilt.48, sa.23, ss.4965-4972, 2024 (SCI-Expanded, Scopus)

23. What Do Breast Cancer Previvors Tell Us About Their Stories? To Know or Not to Know?

USLU Y., ER S., Subaşı Sezgin D., Yeşilyurt A., URAS C.

Seminars in Oncology Nursing , cilt.40, sa.5, 2024 (SCI-Expanded, SSCI, Scopus)

24. Association between multimorbidity and postoperative mortality in patients undergoing major surgery: a prospective study in 29 countries across Europe.

Kamarajah S. K., Kouli O., Ahuja S., Blackwell S., Dhesi J., Docherty A., et al.

Anaesthesia , cilt.79, sa.9, ss.945-956, 2024 (SCI-Expanded, Scopus)

25. Kinesiophobia, physical activity levels and barriers in breast cancer patients, survivors, and healthy controls: A case-control analysis

ALACA N., Karayazi K. T., Arslan D., Karakus M., URAS C.

JOURNAL OF THE PAKISTAN MEDICAL ASSOCIATION , cilt.74, sa.8, ss.1428-1436, 2024 (SCI-Expanded, Scopus)

26. Abstract PS01-01: Feasibility and oncological safety of targeted axillary dissection or sentinel lymph node biopsy in patients with clinically node-positive disease after neoadjuvant chemotherapy in the prospective MF-1803 NEOSENTITURK-study

Cabıoğlu N., Karanlik H., Gulcelik M. A., Kocer H. B., Muslumanoglu M., İgci A., et al.

CANCER RESEARCH , cilt.84, sa.9_Supplement, ss.1, 2024 (SCI-Expanded, Scopus)

27. Comparison of mammography and ultrasound findings in the followup of patients with breast cancer treated with segmental mastectomy followed by intraoperative electron radiotherapy versus external whole breast radiotherapy

Tutar B., ICTEN S. G., Altinok A., Eroz S., Bese N., URAS C.

DIAGNOSTIC AND INTERVENTIONAL RADIOLOGY , cilt.29, sa.6, ss.761-770, 2023 (SCI-Expanded, Scopus, TRDizin)

28. Direct to Implant versus 2-Stage Expander Implant Immediate Breast Reconstruction: Comparison of Incidence and Predictors of Complications

ALTINKAYA A., YAZAR Ş., KARA H., ARIKAN A. E., URAS C.

Acıbadem Üniversitesi Sağlık Bilimleri Dergisi , cilt.14, sa.4, ss.508-515, 2023 (TRDizin)

29. False-positive MRI Findings in Breast Cancer After Neoadjuvant Chemotherapy and Correlation Between Tumor Response Patterns and HER2 Status

Avdan Aslan A., Erdemli S., ERDOĞDU İ. H., Gultekin S., URAS C., Tokat F., et al.

ACTA ONCOLOGICA TURCICA , cilt.56, sa.2, ss.97-105, 2023 (TRDizin)

30. Effect of the COVID-19 pandemic on surgery for indeterminate thyroid nodules (THYCOVID): a retrospective, international, multicentre, cross-sectional study

Medas F., Dobrinja C., Al-Suhaimi E. A., Altmeier J., Anajar S., Arikan A. E., et al.

LANCET DIABETES & ENDOCRINOLOGY , cilt.11, sa.6, ss.402-413, 2023 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

31. Implant selection in natural and stable direct-to-implant reconstruction with ten steps at nipple-sparing mastectomy

Sagir M., Guven E., Eroz S., Uras C.

MEDICINE , cilt.102, sa.19, 2023 (SCI-Expanded, Scopus)

32. Adherence to adjuvant tamoxifen and associated factors in breast cancer survivors

USLU Y., Kocatepe V., Sezgin D. S., URAS C.

SUPPORTIVE CARE IN CANCER , cilt.31, sa.5, 2023 (SCI-Expanded, Scopus)

33. Association of mtDNA Copy Number Variations with Neoadjuvant in Triple Negative Breast Cancer Patients

Manto K., Yilmaz S. U., PALA KARA Z., URAS C., TOKAT F., İNCE Ü., et al.

BREAST , 2023 (SCI-Expanded, Scopus)

34. Evaluation of Patient Satisfaction with Breast Q after Post-mastectomy Hypofractionated Radiotherapy with Immediate Implant Reconstruction

Erdogdu S., Tezcanli E., Sagir M., GÜLLÜOĞLU M. B., URAS C., Bese N.

BREAST , cilt.68, 2023 (SCI-Expanded, Scopus)

35. Assessment High-Risk Breast Cancer in Older Patients: A Comparative Analysis of PREDICT Scores and TAILORx Risk Categorization

Unal C., Ozmen T., Ordu C., URAS C., Kara H., Gokmen E., et al.

EUROPEAN JOURNAL OF BREAST HEALTH , cilt.19, sa.4, ss.325-330, 2023 (ESCI, Scopus, TRDizin) Sürdürülebilir Kalkınma

36. Sentinel lymph node biopsy after nipple-sparing mastectomy in early postoperative period: Is it feasible?

Kara H., Arikan A. E., Dülgeroğlu O., Uras C.

INDIAN JOURNAL OF CANCER , cilt.60, sa.2, ss.237-241, 2023 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

37. Survival results according to Oncotype Dx recurrence score in patients with hormone receptor positive HER-2 negative early-stage breast cancer: first multicenter Oncotype Dx recurrence score survival data of Turkey

Unal C., Ozmen T., Ordu C., Pilanci K. N., Ilgun A. S., Gokmen E., et al.

FRONTIERS IN ONCOLOGY , cilt.13, 2023 (SCI-Expanded, Scopus)

38. Local steroid injection in severe idiopathic granulomatous mastitis as a new first-line treatment modality with promising therapeutic efficacy

Cabioglu N., Uras C., Mutlu H., Sezgin D., Emiroglu S., Dülgeroğlu O., et al.

FRONTIERS IN MEDICINE , cilt.10, 2023 (SCI-Expanded, Scopus)

39. Favorable locoregional control in clinically node-negative hormone-receptor positive breast cancer with low 21-gene recurrence scores: a single-institution study with 10-year follow-up

URAS C., Cabioglu N., TOKAT F., ER Ö., KARA H., KORKMAZ T., et al.

BMC CANCER , cilt.22, sa.1, 2022 (SCI-Expanded, Scopus)

40. Do prognosis and clinicopathological features differ in young early-stage breast cancer?

Arıkan A. E., Kara H., Dülgeroğlu O., Erdoğan E. N., Capkinoglu E., Uras C.

FRONTIERS IN SURGERY , cilt.9, 2022 (SCI-Expanded)

41. Results of Locoregional Radiotherapy or Axillary Dissection in Early Breast Cancer with pN0(is +) and pN1mi Nodal Disease

Altinok A., Tokat F., Ince Ü., Uras C., Bese N.

INDIAN JOURNAL OF SURGERY , cilt.84, ss.697-702, 2022 (SCI-Expanded, Scopus)

42. Impact of preoperative PET/CT for axillary staging in patients with early breast cancer

DÜLGEROĞLU O., ARIKAN A. E., KARA H., URAS C.

ANNALI ITALIANI DI CHIRURGIA , cilt.93, sa.5, ss.504-509, 2022 (SCI-Expanded, Scopus)

43. The impact of surgical delay on resectability of colorectal cancer: An international prospective cohort study

Adamina M., Ademuyiwa A., Adisa A., Bhangu A. A., Bravo A. M., Cunha M. F., et al.

COLORECTAL DISEASE , cilt.24, sa.6, ss.708-726, 2022 (SCI-Expanded, Scopus)

44. Sentinel lymph node biopsy with/without axillary dissection in clinically node-positive breast cancer after neoadjuvant chemotherapy

CABIOĞLU N., KARANLIK H., Gulcelik M. A., Ilgun S., Igci A., URAS C., et al.

ANNALS OF SURGICAL ONCOLOGY , cilt.29, sa.SUPPL 1, ss.69-70, 2022 (SCI-Expanded, Scopus)

45. Has the COVID-19 Pandemic Affected Breast Cancer Stage and Surgical Volume?

KARA H., ARIKAN A. E., DÜLGEROĞLU O., Tutar B., TOKAT F., URAS C.

FRONTIERS IN SURGERY , cilt.9, 2022 (SCI-Expanded, Scopus)

46. Breast Surgery can be Performed Safely During the COVID-19 Pandemic: A Retrospective Single-Center Analysis

Arıkan A. E., Kara H., Dülgeroğlu O., Uras C.

ISTANBUL MEDICAL JOURNAL , cilt.23, sa.1, ss.45-50, 2022 (Hakemli Dergi) Sürdürülebilir Kalkınma

47. Transmesocolic approach in laparoscopic complete mesocolic excision for right sided colon cancers

Çapkınoğlu E., Arıkan A. E., Dülgeroğlu O., Uras C.

VIDEOSURGERY AND OTHER MINIINVASIVE TECHNIQUES , cilt.17, sa.4, ss.699-704, 2022 (SCI-Expanded, Scopus)

48. Comparison of PET-CT and MRI for evaluation of axillary lymph nodes in early breast cancer patients

Dülgeroğlu O., Arıkan A. E., Capkinoglu E., Kara H., Uras C.

ANNALI ITALIANI DI CHIRURGIA , cilt.93, ss.648-655, 2022 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

49. Detachment and embolization of totally implantable central venous access devices: diagnosis and management.

Kara H., Arikan A. E., Dulgeroglu O., Uras C., Icten G. E., Tutar B., et al.

Acta chirurgica Belgica , cilt.122, sa.4, ss.240-247, 2022 (SCI-Expanded, Scopus)

50. Preoperative nasopharyngeal swab testing and postoperative pulmonary complications in patients undergoing elective surgery during the SARS-CoV-2 pandemic

Glasbey J. C., Omar O., Nepogodiev D., Minaya-Bravo A., Bankhead-Kendall B. K., Fiore M., et al.

British Journal of Surgery , cilt.108, sa.1, ss.88-96, 2021 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

51. Correlation between clinicopathologic factors and recurrence score according to TAILOR x risk category in patients with hormone receptor positive early-stage breast cancer

Pilanci K. N., Unal C., Ordu C., Gokmen E., Ozdogan M., Guler N., et al.

Journal of B.U.ON. , cilt.26, sa.6, ss.2266-2273, 2021 (SCI-Expanded, Scopus)

52. Favorable outcome with sentinel lymph node biopsy alone after neoadjuvant chemotherapy in clinically node positive breast cancer at diagnosis: Turkish Multicentric NEOSENTI-TURK MF-18-02-study

CABIOĞLU N., KARANLIK H., Yildirim N., MÜSLÜMANOĞLU M. E., Karadeniz G. C., Can D. T., et al.

EJSO , cilt.47, sa.10, ss.2506-2514, 2021 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

53. The Effect of Primary Surgery in Patients with De Novo Stage IV Breast Cancer with Bone Metastasis Only (Protocol BOMET MF 14-01): A Multi-Center, Prospective Registry Study

Soran A., Dogan L., IŞIK A., Ozbas S., Trabulus D. C., Demirci U., et al.

ANNALS OF SURGICAL ONCOLOGY , cilt.28, sa.9, ss.5048-5057, 2021 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

54. The role of loco-regional treatment in long-term quality of life in de novo stage IV breast cancer patients: protocol MF07-01Q

Soran A., Soyder A., Ozbas S., ÖZMEN V., KARANLIK H., Igci A., et al.

SUPPORTIVE CARE IN CANCER , cilt.29, sa.7, ss.3823-3830, 2021 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

55. Pure Tubular Carcinoma of the Breast: Is Axillary Staging Necessary?

KARA H., ARIKAN A. E., DÜLGEROĞLU O., TOKAT F., URAS C.

Indian Journal of Surgery , cilt.83, ss.322-327, 2021 (SCI-Expanded, Scopus)

56. Nipple-Sparing Mastectomy and Immediate Implant-Based Reconstruction with or Without Skin Reduction in Patients with Large Ptotic Breasts: A Case-Matched Analysis

Yazar S., Bengur F. B., ALTINKAYA A., KARA H., URAS C.

AESTHETIC PLASTIC SURGERY , cilt.45, sa.3, ss.956-967, 2021 (SCI-Expanded, Scopus)

57. The effect of primary surgery in patients with stage IV breast cancer with bone metastasis only (protocol bomet MF14-01); a multi-center, registry study

Soran A., Dogan L., Ozbas S., Isik A., Trablus D., Demirci U., et al.

BREAST , cilt.56, 2021 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

58. Sentinel lymph node biopsy alone in locally advanced breast cancer after neoadjuvant chemotherapy: Turkish multicentric neosenti-turk MF-18-02-study

Cabioglu N., Karanlik H., Muslumanoglu M., Cakmak G. K., Trablus D. C., Tukenmez M., et al.

CANCER RESEARCH , cilt.81, sa.4, 2021 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

59. Elective Cancer Surgery in COVID-19-Free Surgical Pathways During the SARS-CoV-2 Pandemic: An International, Multicenter, Comparative Cohort Study

Arikan A. E., Bilgin I. A., Bozkırlı B., Ceyhan G. O., Kara H., Dülgeroğlu O., et al.

JOURNAL OF CLINICAL ONCOLOGY , cilt.39, sa.1, ss.88-96, 2021 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

60. ASO Author Reflection: Getting Closer to Solving the Mystery Behind Mastalgia: Evening Primrose Oil and Factors Affecting Its Therapeutic Efficacy

Balci F. L., URAS C., Feldman S.

ANNALS OF SURGICAL ONCOLOGY , cilt.27, ss.717-718, 2020 (SCI-Expanded, Scopus)

61. Clinical Factors Affecting the Therapeutic Efficacy of Evening Primrose Oil on Mastalgia

Balci F. L., URAS C., Feldman S.

ANNALS OF SURGICAL ONCOLOGY , cilt.27, sa.12, ss.4844-4852, 2020 (SCI-Expanded, Scopus)

62. Noninvaziv Meme Kanserinde Tedavi Yaklaşımı

Uras C.

Türkiye Klinikleri , cilt.1, ss.18-28, 2020 (Hakemli Dergi) Sürdürülebilir Kalkınma

63. Tek kesiden robotik meme başı koruyucu mastektomi: Arka taraf diseksiyonu ile başlamanın avantajı

Uras C., Arıkan A. E., Kara H., Dülgeroğlu O., Avşar Y.

Turkish Journal of Surgery , cilt.36, sa.3, ss.303-309, 2020 (Hakemli Dergi)

64. Management of Mechanical Problems of Totally Implantable Venous Catheters

Kara H., Arıkan A. E., Dülgeroğlu O., Uras C.

CLINICAL AND EXPERIMENTAL HEALTH SCIENCES , cilt.10, sa.2, ss.81-86, 2020 (SCI-Expanded, ESCI, TRDizin)

65. Management of Occult Contralateral Inguinal Hernia: Diagnosis and Treatment With Laparoscopic Totally Extra Peritoneal Repair

Kara H., Arikan A. E., Dülgeroğlu O., Moldur D., Uras C.

SURGICAL LAPAROSCOPY ENDOSCOPY & PERCUTANEOUS TECHNIQUES , cilt.30, sa.3, ss.245-248, 2020 (SCI-Expanded, Scopus)

66. Comparison of automated versus hand-held breast US in supplemental screening in asymptomatic women with dense breasts: is there a difference regarding woman preference, lesion detection and lesion characterization?

Tutar B., Icten G. E., Guldogan N., Kara H., ARIKAN A. E., Tutar O., et al.

Archives of gynecology and obstetrics , cilt.301, sa.5, ss.1257-1265, 2020 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

67. Role of Sentinel Lymph Node Biopsy During Contralateral Prophylactic Mastectomy

KARA H., ARIKAN A. E., DÜLGEROĞLU O., URAS C.

ISTANBUL MEDICAL JOURNAL , cilt.21, sa.2, ss.97-103, 2020 (TRDizin) Sürdürülebilir Kalkınma

68. Association between ABCB1, ABCG2 carrier protein and COX-2 enzyme gene polymorphisms and breast cancer risk in a Turkish population

Zeliha K. P., Dilek O., Ezgi O., Halil K., URAS C., ÖZHAN G.

SAUDI PHARMACEUTICAL JOURNAL , cilt.28, sa.2, ss.215-219, 2020 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

69. LASER-ASSISTED-INDOCYANINE-GREEN-ANGIOGRAPHY VERSUS CONVENTIONAL ASSESSMENT TO PREDICT OR LOCATE NECROTIC AREAS ON MASTECTOMY FLAPS: A PROSPECTIVE CLINICAL TRIAL

BALCI F. L., URAS C.

JOURNAL OF ISTANBUL FACULTY OF MEDICINE-ISTANBUL TIP FAKULTESI DERGISI , cilt.82, ss.193-198, 2019 (SCI-Expanded, TRDizin)

70. Factors Associated With Complications in Immediate Breast Reconstruction in 1 Stage With Completely Submuscular Implants

Yazar S., ALTINKAYA A., Bengur F. B., Karadag E. C., KARA H., URAS C.

ANNALS OF PLASTIC SURGERY , cilt.83, sa.3, ss.264-270, 2019 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

71. Intravenous ceftriaxone plus clindamycin reduces breast abscess formation in severe lactational mastitis

Balcı F. L., Uras C.

Cumhuriyet Medical Journal , cilt.41, ss.647-652, 2019 (Hakemli Dergi)

72. Cost effectiveness of Gene Expression Profiling in Patients with Early-Stage Breast Cancer in a Middle-Income Country, Turkey: Results of a Prospective Multicenter Study

ÖZMEN V., ÇAKAR B., GÖKMEN E., ÖZDOĞAN M., GÜLER N., URAS C., et al.

EUROPEAN JOURNAL OF BREAST HEALTH , cilt.15, sa.3, ss.183-190, 2019 (TRDizin)

73. Oncologic safety of nipple-sparing mastectomy in patients with short tumor-nipple distance

Balci F. L., Kara H., Dulgeroglu O., Uras C.

BREAST JOURNAL , cilt.25, sa.4, ss.612-618, 2019 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

74. Innovative use of optical coherence tomography catheter via nipple orifice: a case report of first intraductal images of florid ductal hyperplasia

Balci F. L., Uras C., Feldman S. M.

QUANTITATIVE IMAGING IN MEDICINE AND SURGERY , cilt.9, sa.6, ss.1184-1188, 2019 (SCI-Expanded, Scopus)

75. Evaluation of follow-up findings in mammography and ultrasound after intraoperative electron radioteraphy and breast conservation surgery

Altinok A., Soysal B., Arikan E., Kara H., Icten G. E., Bese N., et al.

BREAST , cilt.44, 2019 (SCI-Expanded, Scopus)

76. Is human papillomavirus associated with breast cancer or papilloma presenting with pathologic nipple discharge?

BALCI F. L., URAS C., Feldman S. M.

Cancer Treatment and Research Communications , cilt.19, ss.100122, 2019 (Hakemli Dergi) Sürdürülebilir Kalkınma

77. Combination Technique Is Superior to Dye Alone in Identification of the Sentinel Lymph Node in Male Breast Cancer

Simsek O., Belli A. K., AYDOĞAN F., Karatas A., Canbay E., Kepil N., et al.

AMERICAN SURGEON , cilt.84, sa.12, ss.1957-1960, 2018 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

78. A rare case of pleomorphic adenoma of the breast: Ultrasonography and pathology findings.

Arslan A., Guldogan N., Kapucuoglu N., Esen G., Kara H., Uras C.

The breast journal , cilt.24, sa.6, ss.1069-1070, 2018 (SCI-Expanded, Scopus)

79. Randomized Trial Comparing Resection of Primary Tumor with No Surgery in Stage IV Breast Cancer at Presentation: Protocol MF07-01

Soran A., Ozmen V., Ozbas S., KARANLIK H., Muslumanoglu M., Igci A., et al.

ANNALS OF SURGICAL ONCOLOGY , cilt.25, sa.11, ss.3141-3149, 2018 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

80. Male Breast Cancer: No Evidence of Human Papillomavirus Etiology

ATASOY D., AYDOĞAN F., ERGİN S., MİDİLLİ K., İLVAN Ş., URAS C., et al.

International Journal of Surgery and Medicine , cilt.4, ss.1, 2018 (Hakemli Dergi) Sürdürülebilir Kalkınma

81. value of second look ultrasonography for MRI detected nonmass enhancing lesions

TAŞKIN F., SOYDER A., kuş a., içten g. e., URAS C.

Acıbadem Sağlık Bilimleri , 2018 (Hakemli Dergi)

82. Risk Factor Analysis for Survival of Becker-Type Expander in Immediate Breast Reconstruction.

Yazar S., Karadag E. C., Altinkaya A., Kara H., Uras C.

Aesthetic plastic surgery , cilt.42, sa.4, ss.971-979, 2018 (SCI-Expanded, Scopus)

83. A Simple Flap Design for the Salvage of Immediate Implant-Based Breast Reconstruction.

Yazar S., Altinkaya A., Karadag E. C., Kara H., Uras C.

Annals of plastic surgery , cilt.80, sa.2, ss.109-112, 2018 (SCI-Expanded, Scopus)

84. The satisfaction of patients with breast cancer undergone immediate reconstruction with implant and the effect of radiotherapy

Altinok A. Y., Bese N., Kara H., Yazar S., Unal C.

WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY , cilt.22, sa.1, ss.27-30, 2018 (Hakemli Dergi)

85. Is it oncologically safe to perform nipple-sparing mastectomy in patients with tumor-nipple distance less than 2.0 cm?

Balci F. L., Kara H., Dulgeroglu O., Boler D. E., Uras C.

ANNALS OF SURGICAL ONCOLOGY , cilt.24, ss.226, 2017 (SCI-Expanded, Scopus)

86. Cost effectiveness of Oncotype DX test in patients with early-stage breast cancer in a middle-income country, Turkey: results of a prospective multicenter study

ÖZMEN V., Gokmen E., Atasoy A., Ozdogan M., Guler N., URAS C., et al.

BREAST , cilt.32, 2017 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

87. Metaplastic carcinoma of the breast: A case series and review of the literature

EREN BÖLER D., KARA H., SAĞLICAN Y., TOKAT F., URAS C.

Journal of Oncological Sciences , cilt.2, ss.38-42, 2016 (Hakemli Dergi)

88. Association Between Human Telomerase Reverse Transcriptase Gene Variations and Risk of Developing Breast Cancer.

Oztas E., Kara H., Kara Z., Aydogan M. U., Uras C., Ozhan G.

Genetic testing and molecular biomarkers , cilt.20, sa.8, ss.459-64, 2016 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

89. Correlations Between Oncotype DX Recurrence Score and Classic Risk Factors in Early Breast Cancer: Results of A Prospective Multicenter Study in Turkey.

Özmen V., Atasoy A., Gökmen E., Özdoğan M., Güler N., Uras C., et al.

The journal of breast health , cilt.12, sa.3, ss.107-111, 2016 (Hakemli Dergi)

90. Sentinel lymph node biopsy under fluorescent indocyanin green guidance: Initial experience

AYDOĞAN F., Arikan A. E., Aytac E., Velidedeoglu M., Yilmaz M. H., Sager M. S., et al.

TURKISH JOURNAL OF SURGERY , cilt.32, sa.1, ss.50-53, 2016 (ESCI, Scopus, TRDizin) Sürdürülebilir Kalkınma

91. Impact of Oncotype DX Recurrence Score on Treatment Decisions: Results of a Prospective Multicenter Study in Turkey

Ozmen V., Atasoy A., GÖKMEN E., Ozdogan M., Guler N., URAS C., et al.

CUREUS , cilt.8, sa.3, 2016 (Hakemli Dergi)

92. Robotic single port cholecystectomy (R-LESS-C): Experience in 36 patients

Uras C., Boler D. E., Erguner I., Hamzaoglu İ. H.

ASIAN JOURNAL OF SURGERY , cilt.37, sa.3, ss.115-119, 2014 (SCI-Expanded, Scopus)

93. SURGICAL MANAGEMENT OF PHYLLODES TUMORS OF BREAST

DENİZ B., URAS C., GÜRLÜLER E., HAMİT K., SAĞLICAN Y., GÜRKAN A., et al.

Yeditepe Medical Journal , cilt.7, sa.26, ss.613-618, 2013 (Hakemli Dergi)

94. Laparoscopic resection of colonic lipomas: When and why?

Böler D., Baca B., Uras C.

The American journal of case reports , cilt.14, ss.270-5, 2013 (Hakemli Dergi)

95. What Have We Gained by Performing Robotic Rectal Resection? Evaluation of 64 Consecutive Patients Who Underwent Laparoscopic or Robotic Low Anterior Resection for Rectal Adenocarcinoma

Erguner I., Aytac E., Boler D. E., Atalar B., Baca B., Karahasanoglu T., et al.

SURGICAL LAPAROSCOPY ENDOSCOPY & PERCUTANEOUS TECHNIQUES , cilt.23, sa.3, ss.316-319, 2013 (SCI-Expanded, Scopus)

96. Endoloop Retraction Technique in Single-Port Laparoscopic Cholecystectomy: Experience in 27 Patients

Uras C., Boler D. E.

JOURNAL OF LAPAROENDOSCOPIC & ADVANCED SURGICAL TECHNIQUES , cilt.23, sa.6, ss.545-548, 2013 (SCI-Expanded, Scopus)

97. Intracystic Papillary Carcinoma Of The Breast Report of 2 Cases

EREN BÖLER D., TOKAT F., URAS C.

Yeditepe Medical Journal , cilt.7, sa.26, ss.640-643, 2013 (Hakemli Dergi)

98. Radio-guided lymph node biopsy for the diagnosis of axillary lymphadenopathy

ÖZBEN V., AYDOĞAN F., Atasoy D., Ferahman M., YILMAZ M. Y., Esen G., et al.

NUCLEAR MEDICINE COMMUNICATIONS , cilt.32, sa.3, ss.233-237, 2011 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

99. A complication of radioisotope guided occult lesion localization: Intraductal injection

AYDOĞAN F., ÖZBEN V., KARACA F. C., YILMAZ M. H., ÇELİK V., URAS C.

Meme Hastalıkları Dergisi , cilt.16, ss.59-60, 2009 (Hakemli Dergi)

100. A comparison of the adverse reactions associated with isosulfan blue versus methylene blue dye in sentinel lymph node biopsy for breast cancer

AYDOĞAN F., ÇELİK V., URAS C., SALİHOĞLU Z., Topuz U.

American Journal of Surgery , cilt.195, sa.2, ss.277-278, 2008 (SCI-Expanded, Scopus)

101. Rectal duplication as an unusual cause of chronic perianal fistula in an adult: Report of a case

Altinli E., Balkan T., URAS C., Dogusoy G., Akcal T., Balcisoy U.

Surgery Today , cilt.34, sa.9, ss.796-798, 2004 (SCI-Expanded, Scopus)

102. Enteroclysis-guided laparoscopic adhesiolysis in recurrent adhesive small bowel obstructions

PEKMEZCİ S., Altinli E., Saribeyoglu K., Carkman S., Hamzaoglu İ. H., Paksoy M., et al.

SURGICAL LAPAROSCOPY ENDOSCOPY & PERCUTANEOUS TECHNIQUES , cilt.12, sa.3, ss.165-170, 2002 (SCI-Expanded, Scopus)

103. Anthropometric measurements in male breast cancer

Altinli E., Gorgun E., Karabicak I., URAS C., Unal H., Akcal T.

Obesity Surgery , cilt.12, sa.6, ss.869-870, 2002 (SCI-Expanded, Scopus)

104. Mammographic density increase in women receiving different hormone replacement regimens

Erel C., Esen G., Seyisoglu H., Elter K., Uras C., Ertungealp E., et al.

MATURITAS , cilt.40, sa.2, ss.151-157, 2001 (SCI-Expanded, Scopus)

105. Laparoscopic approach to hepatic hydatid disease

Ertem M., Uras C., Karahasanoglu T., Erguney S., Alemdaroglu K.

DIGESTIVE SURGERY , cilt.15, sa.4, ss.333-336, 1998 (SCI-Expanded, Scopus)

106. Restorative caecogastroplasty reconstruction after pylorus-preserving near-total gastrectomy: A preliminary study

Uras C., Yigitbasi R., Erturk S., Hamzaoglu İ. H., SAYMAN H. B.

BRITISH JOURNAL OF SURGERY , cilt.84, sa.3, ss.406-409, 1997 (SCI-Expanded, Scopus)

Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 49

1. Evaluation of Clinicopathological Features and Prognoses of Male Patients with Breast Lymphoma

Azizy A., Doğan İ., Bozkurt M., Dülgeroğlu O., Yücel S., Yıldız İ., et al.

San Antonio Breast Cancer Symposium (SABCS) 2025, Texas, Amerika Birleşik Devletleri, 9 - 12 Aralık 2025, ss.2028, (Özet Bildiri)

2. Comparison of Clinicopathological Features and Prognoses in Male and Female Patients with Denovo Metastatic Breast Cancer

Doğan İ., Azizy A., Subaşı I., Yıldız İ., Arıcan A., Yücel S., et al.

San Antonio Breast Cancer Symposium (SABCS) 2025, Texas, Amerika Birleşik Devletleri, 9 - 12 Aralık 2025, ss.2062, (Özet Bildiri)

3. Eﬀect of Primary Breast Surgery on Prognosis in Breast Cancer Patients with Isolated Bone Metastases

Doğan İ., Azizy A., Yücel S., Subaşı I., Bozkurt M., Dülgeroğlu O., et al.

San Antonio Breast Cancer Symposium (SABCS) 2025, Texas, Amerika Birleşik Devletleri, 9 - 12 Aralık 2025, ss.2053, (Özet Bildiri)

4. Evaluation of Clinicopathological Features and Prognoses of Female Breast Sarcoma Patients

Azizy A., Doğan İ., Dülgeroğlu O., Yücel S., Bozkurt M., Yıldız İ., et al.

San Antonio Breast Cancer Symposium (SABCS) 2025, Texas, Amerika Birleşik Devletleri, 9 - 12 Aralık 2025, ss.2044, (Özet Bildiri)

5. PATIENT REPORTED OUTCOMES AND LYMPHEDEMA IN NODE-POSITIVE BREAST CANCER IN THE EARLY POSTOPERATIVE PERIOD AFTER NEOADJUVANT CHEMOTHERAPY IN THE PROSPECTIVE NEOSENTITURK-trial MF18-03

Cabioglu N., Kilic H. G., Bozdogan A., Kilic B. R., USLU Y., Ozgorgu E., et al.

San Antonio Breast Cancer Symposium, San-Antonio, Kuzey Mariana Adaları, 10 - 13 Aralık 2024, cilt.31, (Özet Bildiri)

6. Papiller Tiroid Kanserinde Profilaktik Santral Leni Nodu Diseksiyonu

ARIKAN A. E., RAMOĞLU N., DÜLGEROĞLU O., ÇAPKINOĞLU E., KARA H., URAS C.

12. Ulusal Endokrin Cerrahi Kongresi, Antalya, Türkiye, 13 - 16 Şubat 2025, (Özet Bildiri)

7. THE EFFECT OF MANUAL LYMPH DRAINAGE IN THE TREATMENT OF BREAST EDEMA THAT MAY OCCUR IN PATIENTS UNDERGOING BREAST-CONSERVING SURGERY AND ADJUVANT RADIOTHERAPY: RANDOMIZED CONTROLLED STUDY

ALACA N., Erkol F. N., URAS C.

Breastanbul 2024, 10 Ekim 2024, (Özet Bildiri)

8. COMPARISON OF GENESWELL BCT SCORE WITH ONCOTYPE DX RECURRENCE SCORE FOR RISK CLASSIFICATION IN TURKISH WOMEN WITH HORMONE RECEPTOR-POSITIVE, HER2- NEGATIVE, EARLY BREAST CANCER

URAS C., ARIKAN A. E., TOKAT F., KORKMAZ T., SAHAR A. A., SUBAŞI SEZGİN D.

Breastanbul, 6th Breast Cancer Conference, İstanbul, Türkiye, 10 - 12 Ekim 2024, cilt.15, (Özet Bildiri)

9. Meme kanserinde MRG bulguları ile metastatic aksiller lenf nodu arasındaki ilişki.

Altıntaş D. D., Icten S. G., Taşkın F., Uras C.

63. 45. Ulusal Radyoloji Kongresi (Turkrad) , Antalya, Türkiye, 12 - 16 Kasım 2024, ss.1-2, (Özet Bildiri)

10. Sensitivity of 18F-fluorocholine PET localization in complicated primary hyperparathyroidism case

ARIKAN A. E., DÜLGEROĞLU O., RAMOĞLU N., ÜNAL K., ÇELİK Ö., URAS C.

Turkish & Greek Endocrine Surgery Joint Summit, İstanbul, Türkiye, 26 Ekim 2024, (Özet Bildiri)

11. Factors associated with upgrade after surgical excision in patients diagnosed with ductal carcinoma in situ via percutaneous biopsy

Akın M., Taşkın F., İçten S. G., Tunçbilek N., Çelik L., Tokat F., et al.

BREASTANBUL 2024, İstanbul, Türkiye, 12 - 13 Ekim 2024, ss.22-23, (Özet Bildiri)

12. EVALUATION OF PEPTIDE PROFILES OF BREAST-CANCER TISSUES BY PROTEOMIC METHODS

Uçal Y., Ergun B., Kerem Kayhan C., Tokat F., Kara H., Korkmaz T., et al.

Uluslararası Proteomik Kongresi, Kocaeli, Türkiye, 11 - 12 Ekim 2024, ss.23, (Özet Bildiri)

13. Comparison of the quantitative and semi-quantitative analysis of ultrafast dynamic contrast-enhanced MRI and apparent diffusion coefficient value in the differential diagnosis of breast lesions.

Akın M., Icten S. G., Uras C., Denizoğlu N., Zeynelova A., Taşkın F.

60. Annual Meeting of European Society of Breast Imaging (EUSOBI) , Lisbon, Portekiz, 3 - 05 Ekim 2024, ss.1-2, (Özet Bildiri)

14. Relationship between MRI findings and axillary lymph node metastasis in breast cancer.

Altıntaş D. D., Esen İçten S. G., Taşkın F., Uras C.

59. Annual Meeting of European Society of Breast Imaging (EUSOBI), Lisbon, Portekiz, 3 - 05 Ekim 2024, ss.1-2, (Özet Bildiri)

15. Relationship between MRI and axillary lymph node metastasis in breast cancer

Deniz Altıntaş D., Esen İçten G., Taşkın F., Uras C.

EUSOBI 2024, Lisbon, Portekiz, 2 - 04 Ekim 2024, ss.148-149, (Özet Bildiri)

16. Comparison of the quantitative and semi-quantitative analysis of ultrafast dynamic contrast-enhanced MRI and apparent diffusion coefficient value in the differential diagnosis of breast lesions

Akın M., İçten S. G., Uras C., Denizoğlu N., Dolu A., Zeynelova A., et al.

EUSOBI 2024, Lisbon, Portekiz, 3 - 05 Ekim 2024, ss.14-15, (Özet Bildiri)

17. Thyroid Incidentalomas: an Under-estimated Reality in Breast Cancer Patients

ARIKAN A. E., DÜLGEROĞLU O., RAMOĞLU N., BOZKURT S. B., URAS C.

10th Biennial Congress of the European Society of Endocrine Surgeons, Rome, İtalya, 23 - 25 Mayıs 2024, (Özet Bildiri)

18. Diagnostic efficay of hand-held breast ultrasound and automatic breast ultrasound as second look ultrasound techniques for detection of lesions detected at breast MRI

Parlakkılıç U. T., Esen S. G., Kayadibi Y., Taşkın F., Uras C.

58. European Congress of Radiology (ECR), Vienna, Avusturya, 28 Şubat - 03 Mart 2024, ss.1-2, (Tam Metin Bildiri)

19. Loco-regional Treatment in De Novo Bone Only Metastatic Breast Cancer; Prospective, Multi-Institutional Real-World Data, BOMETIN, Protocol MF14-1a

Soran A., Ozbas S., Dogan L., Trabulus D. C., El-Azrhi J., Senol K., et al.

San Antonio Breast Cancer Symposium, San-Antonio, Kuzey Mariana Adaları, 5 - 09 Aralık 2023, cilt.84, (Özet Bildiri)

20. Radiation Toxicity and Treatment Outcomes in Breast Cancer Patients with ATM Pathogenic and VUS Mutations: Implications for Personalized Therapy

Tezcanli E., Eroz S., Ozbek U., Yesilyurt A., Uras C., Bese N.

San Antonio Breast Cancer Symposium, San-Antonio, Kuzey Mariana Adaları, 5 - 09 Aralık 2023, cilt.84, (Özet Bildiri)

21. Video yardımlı meme başı koruyucu mastektomi

SAYLIK O., TEMUR M., ARIKAN A. E., DÜLGEROĞLU O., KARA H., URAS C.

23. Ulusal Cerrahi Kongresi, Antalya, Türkiye, 24 - 28 Nisan 2024, (Özet Bildiri)

22. AXSANA-EUBREAST-03: Klinik Nod Pozitif Meme Kanseri Hastalarında Neoadjuvan Kemoterapi Sonrası Aksiller Evrelemede Kullanılan Farklı Cerrahi Metotların Değerlendirildiği Uluslararası Prospektif Çok Merkezli Kohort Çalışması: Preliminar Sonuçlar

TEKİN H., KARADENİZ ÇAKMAK G., SEZER Y. A., UĞURLU M. Ü., KARANLIK H., GÜNAY S., et al.

23. Ulusal Cerrahi Kongresi, Antalya, Türkiye, 24 - 28 Nisan 2024, (Özet Bildiri)

23. Local Steroid Injection in Severe Idiopathic Granulomatous Mastitis as a New First-line Treatment Modality with Promising Therapeutic Efficacy

Cabioğlu N., Uras C., Emiroğlu S., Sezgin D. S., Mutlu H., Tükenmez M., et al.

24th Annual Meeting of The American Society of Breast Surgeons (ASBrS), Mississippi, Amerika Birleşik Devletleri, 26 - 30 Nisan 2023, (Özet Bildiri)

24. Combined Analysis of the MF18-02/03 Neosentiturk Studies: Factors Predicting Recurrence in ycN0/ypN-positive Breast Cancer with Sentinel Lymph Node Biopsy - Or Targeted Axillary Dissection - Alone After Neoadjuvant Chemotherapy

CABIOĞLU N., Muslumanoglu M., Igci A., KARANLIK H., TÜKENMEZ M., Gulcelik M. A., et al.

24th Annual Meeting of The American Society of Breast Surgeons (ASBrS), Mississippi, Amerika Birleşik Devletleri, 26 - 30 Nisan 2023, (Özet Bildiri)

25. Locoregional Treatment Improves Survival in De Novo Bone-only Metastatic Breast Cancer: Long-term Results of the Prospective, Multi-institutional Study - Protocol BOMET MF14-01

Soran A., Dogan L., Isik A., Ozbas S., Can-Trabulus D., Demirci U., et al.

24th Annual Meeting of The American Society of Breast Surgeons (ASBrS), Mississippi, Amerika Birleşik Devletleri, 26 - 30 Nisan 2023, cilt.30, (Özet Bildiri)

26. AXILLARY NODAL RECURRENCE IS RARE IN PATIENTS WITH NODE-POSITIVE BREAST CANCER UNDERGOING SLNB FOLLOWING NEOADJUVANT CHEMOTHERAPY : EARLY RESULTS OF THE NEOSENTITURK-TRIAL/MF-18-03

Cabioglu N., KARANLIK H., Gulcelik M. A., Igci A., Muslumanoglu M., Kocer H. B., et al.

San Antonio Breast Cancer Symposium, San-Antonio, Kuzey Mariana Adaları, 6 - 10 Aralık 2022, cilt.83, (Özet Bildiri)

27. AXSANA: EUBREAST çalışma grubunun klinik nod pozitif meme kanseriAXSANA: kanserihastalarında neoadjuvan kemoterapi sonrası aksiller evrelemede kullanılanhastalarında kullanılanfarklı cerrahi metotları değerlendirdiği uluslararası prospektif çok merkezlifarklı merkezlikohort çalışması (NCT 0437365)

KARADENİZ ÇAKMAK G., SEZER Y. A., UĞURLU M. Ü., KARANLIK H., YILMAZ O. C., ÖZKAN GÜRDAL S., et al.

22. Ulusal Cerrahi Kongresi, Antalya, Türkiye, 23 Mart 2022, (Özet Bildiri)

28. Baştan Klinik Aksilla Pozitif Hastalarda Neoadjuvan Kemorterapi Sonrası Sadece Sentinel Lenf Nodu Uygulanan Hastalarda Lokal ve Genel Sağkalım:Çok Merkezli MF-18-02 Çalışması

CABIOĞLU N., KARANLIK H., YILDIRIM N., KARADENİZ ÇAKMAK G., MÜSLÜMANOĞLU M. E., URAS C., et al.

15.Ulusal Meme Hastalıkları Kongresi, Türkiye, 17 - 20 Ekim 2019, (Özet Bildiri)

29. İNTRAOPERATİF ELEKTRON RADYOTERAPİNİN CERRAHŞ UYGULAMA ÜZERİNE ETKİSİ

KARA H., URAS C.

15. ULUSAL MEME HASTALIKLARI KONGRESİ, Türkiye, 17 - 20 Ekim 2019, (Özet Bildiri)

30. Factors Associated with Complications in immediate Breast Reconstruction in One-stage with Submuscular Implant

ALTINKAYA A., YAZAR Ş., BENGÜR F. B., KARADAĞ E. Ç., KARA H., URAS C.

Breastanbul 2018 3rd Breast Cancer Conference, İstanbul, Türkiye, 11 - 13 Ekim 2018, (Özet Bildiri)

31. Adenoid Cystic Carcinoma: Presentation of four cases

ARIKAN A. E., KARA H., TOKAT F., URAS C.

Breastanbul 2018 3rd Breast Cancer Conference, 11 - 13 Ekim 2018, (Özet Bildiri)

32. Axillary Staging in Pure Tubular Carcinoma: Is It Necessary?

KARA H., ARIKAN A. E., TOKAT F., URAS C.

Breastanbul 2018 3rd Breast Cancer Conference, Türkiye, 11 - 13 Ekim 2018, (Özet Bildiri)

33. Predictivity of Preoperative PET-CT for Axillary Lymph Node Status in patients with Early Breast Cancer

URAS C., DÜLGEROĞLU O., ARIKAN A. E., KARA H., BALCI F. L.

Breastanbul 2018 3rd Breast Cancer Conference, İstanbul, Türkiye, 11 Ekim - 13 Ocak 2018, (Özet Bildiri) Sürdürülebilir Kalkınma

34. Positron Emission Mammography in management of new diagnosed breast cancer routine management

Guner L., Unal K., Tutar B., Kara H., Icten G. E., Uras C., et al.

Annual Meeting of the Society-of-Nuclear-Medicine-and-Molecular-Imaging (SNMMI), Pennsylvania, Amerika Birleşik Devletleri, 23 - 26 Haziran 2018, cilt.59, (Özet Bildiri) Sürdürülebilir Kalkınma